Compare single intensity-modulated radiotherapy to concurrent chemoradiotherapy in patients with node-recurrence esophageal cancer after radical surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002782

Enrollment

Unknown

Registered

2012-03-25

Start date

2012-11-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

A:single intensity-modulated radiotherapy

B:concurrent DDP/5FU chemoradiotherapy

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. node-recurrence esophageal cancer after radical surgery; 2. Male and female aged 18 to 70 years old; 3. Karnofsky performance status not less than 70; 4. Appropriate haematological, liver and renal function.

Exclusion criteria

Exclusion criteria: 1. Serious complications (severe heart disease and tendency to bleeding); 2. Previous treatment with radiotherapy or chemotherapy; 3. Distant organ metastases.

Design outcomes

Primary

Measure	Time frame
Progress-free survival ;	—

Secondary

Measure	Time frame
Response Rate;	—

Countries

China

Contacts

Public ContactZHU Qing-shan

zqs619@sohu.com+86 13663072719

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026